StockData
BioAdaptives, Inc. logo

BioAdaptives, Inc. (BDPT) income statement

BDPTOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 3/30
$0.00−0.00 (-5.56%)

Close on Oct 19, 2026Market cap $478.03KP/E –Yield –

BioAdaptives, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
77.4%
Operating margin
-3557.0%
Net margin
-4553.2%
Return on equity, FY2025
86.7%

Financial strength

Current ratio
0.04
Debt to equity
–
Debt to assets
–
Cash to current liabilities
1.6%

Valuation

P/E ratio
–
Price to sales
18.70
Price to book
–
Dividend yield
–

See a number that looks wrong?